Dean Y. Li

Companies

• Recursion PharmaceuticalsBoard member Apr 15, 2021 to now¹
• Merck & Co.Executive VP & President, MRL Jan 7, 2021 to now²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Merck & Co. MRK94,431 shares³$14.1M at $149.02May 7, 2026
• Recursion Pharmaceuticals RXRX1,894,329 shares⁴$6.9M at $3.63Jul 2, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 1, 2026Granted 3,747 shares of Recursion Pharmaceuticals⁴
• Jun 17, 2026Granted 88,424 shares of Recursion Pharmaceuticals⁵
• Apr 29, 2026Shares withheld for tax 2,326 shares at $110.03 of Merck & Co.⁶
• Apr 29, 2026Exercised options 4,722 shares at $110.03 of Merck & Co.⁶
• Apr 1, 2026Granted 3,268 shares of Recursion Pharmaceuticals⁷
• Feb 10, 2026Sold 10,235 shares at $117.52 of Merck & Co.⁸
• Feb 4, 2026Sold 15,087 shares at $118.77 of Merck & Co.⁹
• Feb 4, 2026Exercised options 15,087 shares at $56.04 of Merck & Co.⁹
• Jan 26, 2026Granted 20,469 shares at $107.40 of Merck & Co.¹⁰
• Jan 2, 2026Granted 2,381 shares of Recursion Pharmaceuticals¹¹
• Oct 1, 2025Granted 1,961 shares of Recursion Pharmaceuticals¹²
• Jul 1, 2025Granted 1,949 shares of Recursion Pharmaceuticals¹³
• Jun 18, 2025Granted 22,016 shares of Recursion Pharmaceuticals¹⁴
• Apr 1, 2025Granted 2,268 shares of Recursion Pharmaceuticals¹⁵
• Jan 27, 2025Granted 32,621 shares at $97.94 of Merck & Co.¹⁶
• Jan 2, 2025Granted 1,647 shares of Recursion Pharmaceuticals¹⁷
• Oct 1, 2024Granted 1,925 shares of Recursion Pharmaceuticals¹⁸
• Jul 1, 2024Granted 1,592 shares of Recursion Pharmaceuticals¹⁹
• Jun 3, 2024Granted 13,097 shares of Recursion Pharmaceuticals²⁰
• Apr 1, 2024Granted 1,267 shares of Recursion Pharmaceuticals²¹
• Feb 9, 2024Sold 14,702 shares at $125.50 of Merck & Co.²²
• Feb 9, 2024Exercised options 14,702 shares at $62.07 of Merck & Co.²²
• Jan 22, 2024Granted 25,760 shares at $119.43 of Merck & Co.²³
• Jan 9, 2024Sold 962 shares at $14.03 of Recursion Pharmaceuticals²⁴
• Jan 9, 2024Sold 28,038 shares at $13.65 of Recursion Pharmaceuticals²⁴